We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Immune Response Settles Shareholder Suits

Law360 (November 15, 2006, 12:00 AM EST) -- The Immune Response Corp. said Tuesday that it will pay nearly $10 million to settle a pair of securities class action lawsuits that accused it of misrepresenting the efficacy of its AIDS-treatment drug Remune.

In the federal case, which is still subject to court approval, Immune Response agreed to pay the affected shareholders $9.6 million. Meanwhile, in the related case before the California state courts, the pharmaceutical company agreed to pay $250,000 and adopt certain corporate governance requirements.

A settlement approval hearing on the state case...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.